Darwin AG (XETRA:7V0) — Market Cap & Net Worth
Market Cap & Net Worth: Darwin AG (7V0)
Darwin AG (XETRA:7V0) has a market capitalization of $100.20 Million (€85.71 Million) as of June 18, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #19271 globally and #1774 in its home market, demonstrating a 27.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Darwin AG's stock price €8.30 by its total outstanding shares 12000000 (12.00 Million). Review 7V0 current and long-term liabilities to assess the company's total debt and financial obligations.
Darwin AG Market Cap History: 2023 to 2026
Darwin AG's market capitalization history from 2023 to 2026. Data shows change from $477.59 Million to $116.44 Million (-42.11% CAGR).
Darwin AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Darwin AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.64x
Darwin AG's market cap is 14.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
20.07x
Darwin AG's market cap is 20.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $477.59 Million | $18.17 Million | $39.71K | 26.29x | 12026.06x |
| 2024 | $370.37 Million | $25.29 Million | $18.46 Million | 14.64x | 20.07x |
Competitor Companies of 7V0 by Market Capitalization
Companies near Darwin AG in the global market cap rankings as of June 18, 2026.
Key companies related to Darwin AG by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #442 globally with a market cap of $63.33 Billion USD.
- UCB SA (BR:UCB): Ranked #550 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #574 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $453.17 |
| #442 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $63.33 Billion | $614.73 |
| #550 | UCB SA | BR:UCB | $49.68 Billion | €250.00 |
| #574 | Argen-X | BR:ARGX | $47.14 Billion | €755.80 |
Darwin AG Historical Marketcap From 2023 to 2026
Between 2023 and today, Darwin AG's market cap moved from $477.59 Million to $ 116.44 Million, with a yearly change of -42.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €116.44 Million | +7.79% |
| 2025 | €108.03 Million | -70.83% |
| 2024 | €370.37 Million | -22.45% |
| 2023 | €477.59 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Darwin AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.20 Million USD |
| MoneyControl | $100.20 Million USD |
| MarketWatch | $100.20 Million USD |
| marketcap.company | $100.20 Million USD |
| Reuters | $100.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Darwin AG
Darwin AG operates in the healthcare industry. The company offers dietary supplements and cosmetics products. It also provides consulting and support services. The company was incorporated in 2021 and is based in Munich, Germany.